FDA Clearance Tracker · P950005
WEBSTER DIAG./ABLATION DEFLECTABLE TIP CATHETER
Last checked: Nov 20, 2026Latest source record: Sep 30, 1997 (this decision)Source: openFDAMethods & limitations
Decided
Sep 30, 1997
Approved
Time to decision
911 days
Received Apr 3, 1995. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P950005
- Device name
- WEBSTER DIAG./ABLATION DEFLECTABLE TIP CATHETER
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Apr 3, 1995
- Decided
- Sep 30, 1997
- Decision
- Approved
- Supplements
- 86 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Cordis Webster Diagnostic/Ablation Deflectable Tip Catheter. This device includes the following models: six curve types (A, B, C, D, E, and F); tip electrode (4mm tip large and grooved); connector type [Redel 10-pin connector (temperature sensing version) and Nexus plug (non-temperature-sensing version)]; spacing [standard 2-5-2 spacing (center to center measurement of ring electrode spacing)]. This device is indicated for cardiac electrophysiological mapping and for use with a compatible RF generator for: interruption of accessory atrioventricular (AV) condution pathways associated with tachycardia; the treatment of AV nodal re-entrant tachycardia; and, creation of complete AV nodal block in patients with a difficult to control ventricular response to an atrial arrhythmia.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.